Abstract:BACKGROUND:Transforming growth factor beta-induced (TGFBI) protein has been found expressed in several cancer types, and expression levels of TGFBI can affect the cancer patients' outcomes, but the role of TGFBI in glioblastoma multiforme (GBM) remains obscure.METHODS:The TGFBI expression levels in GBM were performed via Gene Expression Profiling Interactive Analysis (GEPIA) and UALCAN databases. Further, the mutations types of TGFBI were analyzed by using the cBioportal dataset. LinkedOmics selected correlated genes, kinases, and microRNA (miRNA) targets of TGFBI. GEPIA conducted the prognostic value of TGFBI and correlated genes. Then, the relationship between TGFBI and immune infiltrates was performed by Tumor Immune Estimation Resource (Timer). We compared the TGFBI protein expression levels in GBM and control samples through the Human Protein Atlas (HPA). Finally, the GSCAlite was used to achieve the drugs, and molecules target the TGFBI and significantly correlated genes.RESULTS:TGFBI is significantly overexpressed in GBM, but the clinical features do not have considerable influence on TGFBI expression levels. Overexpression of TGFBI acts as an adverse biomarker of GBM. The enrichment function of TGFBI showed that the main biological functions, including extracellular matrix (ECM) organization, angiogenesis, leukocyte migration, T cell activation, cell cycle G2/M phase transition, and growth factor binding. About the significant correlated genes, overexpression of mitogen-activated protein kinase 13 (MAPK13) [Log-rank P=0.08 HR (high) =1.4], myosin IG (MYO1G) [Log-rank P=0.06 HR (high) =1.4], plasminogen activator urokinase receptor (PLAUR) [Log-rank P=0.03 HR (high) =1.5], thrombomodulin (THBD) [Log-rank P=0.028 HR (high) =1.5] indicated the poor prognosis of GBM. Further, TGFBI had a significant association with dendritic cell (DC) infiltrates (cor =0.516, P=9.00e-30). The higher the DC infiltration, the shorter survival of GBM. TGFBI protein expression levels were not significantly different in GBM and normal tissue. Finally, TGFBI is associated with resistance to belinostat, LAQ824, CAY10603, CUDC-101, methotrexate, 5-fluorouracil, and navitoclax.CONCLUSIONS:In the present study, we showed TGFBI was overexpressed in GBM, and TGFBI is associated with DC cell infiltrates. Overexpression of TGFBI and high DC infiltration might be an adverse biomarker of GBM. Finally, TGFBI is associated with tumor multi-drug resistance.

Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1

Expression and Functional Roles of Smad1 and Bmpr-Ib in Glioma Development

BMP4 Reverses Multidrug Resistance Through Modulation of BCL-2 and GDNF in Glioblastoma

Reduced Expression of BMPR-IB Correlates with Poor Prognosis and Increased Proliferation of Breast Cancer Cells.

RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma

Impact of Nuclear Peripheral Chromatin Lamin LMNB1 Gene in the Proliferation and Migration of Glioma Cells

RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 Pathway

RBM17 Controls Apoptosis and Proliferation to Promote Glioma Progression

Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP

RBM24 Suppresses the Tumorigenesis of Glioblastoma by Stabilizing LATS1 mRNA

NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation

Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling.

BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells

Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway

BRG1 Expression is Increased in Human Glioma and Controls Glioma Cell Proliferation, Migration and Invasion in Vitro

The Effect of BMP4 on Multidrug Resistance in Glioblastoma and the Mechanism Study

PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway

Comprehensively Investigating the Expression Levels and the Prognostic Role of Transforming Growth Factor Beta-Induced (TGFBI) in Glioblastoma Multiforme

RBM5 Inhibits Tumorigenesis of Gliomas Through Inhibition of Wnt/β-catenin Signaling and Induction of Apoptosis

BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.

Neuroglobin Promotes the Proliferation and Suppresses the Apoptosis of Glioma Cells by Activating the PI3K/AKT Pathway.